REFERENCES
- Ahn Y, Horstman L. Idiopathic thrombocytopenic purpura: pathophysiology and management. Int J Hematol 2002; 76: 123–131
- Kravitz M, Shoenfeld Y. Autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS. Am J Hematol 2005; 80: 232–242
- Bidot C, Jy W, Horstman L, et al. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). Am J Hematol 2006; 81: 391–396
- Kuwana M, Kurata Y, Fujimura K, et al. Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura. J Thromb Haemost 2006; 4: 1936–1943
- Bidot C, Jy W, Horstman L, Ahn E, et al. Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission. Br J Hematol 2005; 128: 366–372
- Dash S, Marwaha R, Mohanty S. Lupus anticoagulant in immune thrombocytopenic purpura. Indian J Pediatr 2004; 71: 505–507
- Ahluwalia J, Singh S, Garewal G. Antiphospholipid antibodies in children with systemic lupus erythematosus. Rheumatol Int 2005; 25: 530–535
- Sakai M, Shirahata A, Akatsuka J, et al. Antiphospholipid antibodies in children with idiopathic thrombocytopenic purpura. Jpn J Clin Hematol 2002; 43: 821–7
- Arnout J, Vermylen J. Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease. J Thromb Haemost 2002; 1: 931–942
- Atsumi T, Furukawa S, Amengual O, et al. Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis. Lupus 2005; 14: 499–504
- Bidot C, Jy W, Horstman L, et al. Factor VII/VIIa: a new antigen in the antiphospholipid antibody syndrome. Br J Hematol 2003; 120: 618–626
- Hazzan R, Mukamel M, Yacobovich J, et al. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura. Pediatr Blood Cancer 2006; 47: 657–659
- Altintas A, Ozel A, Okur N, et al. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura. J Thromb Thrombolysis 2007; 24: 163–168